These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35880673)

  • 21. The use of laser lead extraction sheath in the presence of supra-cardiac occlusion of the central veins for cardiac implantable electronic device lead upgrade or revision.
    Al-Maisary S; Romano G; Karck M; De Simone R; Kremer J
    PLoS One; 2021; 16(5):e0251829. PubMed ID: 33989335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome.
    del Río A; Anguera I; Miró JM; Mont L; Fowler VG; Azqueta M; Mestres CA;
    Chest; 2003 Oct; 124(4):1451-9. PubMed ID: 14555579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and effectiveness of transvenous extraction of pacemaker and implantable cardioverter-defibrillator leads in patients under or over 80 years of age.
    Kempa M; Budrejko S; Piepiorka M; Rogowski J; Raczak G; Kozłowski D
    Kardiol Pol; 2013; 71(2):130-5. PubMed ID: 23575705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous lead extraction and repositioning: An effective and safe therapeutic strategy for early ventricular lead perforation with dislocation both inside and outside the pericardial sac following a cardiac device implantation.
    Archontakis S; Sideris K; Aggeli K; Gatzoulis K; Demosthenous M; Tolios P; Lozos V; Koumallos N; Limperiadis D; Tousoulis D; Kallikazaros I; Sideris S
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):299-307. PubMed ID: 30516299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic transvenous pacemaker/implantable cardioverter defibrillator leads implantation induced pathological changes].
    Li Y; Dykoski R; Li J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 May; 43(5):423-7. PubMed ID: 26419988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial experience of pacemaker and implantable cardioverter defibrillator lead extraction with the new GlideLight 80 Hz laser sheaths.
    Hakmi S; Pecha S; Sill B; Reiter B; Willems S; Aydin MA; Yildirim Y; Reichenspurner H; Treede H
    Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):56-60. PubMed ID: 24087832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical epicardial left ventricular lead versus coronary sinus lead placement in biventricular pacing.
    Mair H; Sachweh J; Meuris B; Nollert G; Schmoeckel M; Schuetz A; Reichart B; Daebritz S
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):235-42. PubMed ID: 15691676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie.
    Fauchier L; Alonso C; Anselme F; Blangy H; Bordachar P; Boveda S; Clementy N; Defaye P; Deharo JC; Friocourt P; Gras D; Halimi F; Klug D; Mansourati J; Obadia B; Pasquié JL; Pavin D; Sadoul N; Taieb J; Piot O; Hanon O
    Arch Cardiovasc Dis; 2016 Oct; 109(10):563-585. PubMed ID: 27595465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
    J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transvenous cardiac implantable electronic device implantation in patients with persistent left superior vena cava in a tertiary center.
    Chen X; Yu Z; Bai J; Wang W; Qin S; Wang J; Sun Z; Han F; Su Y; Ge J
    J Interv Card Electrophysiol; 2018 Nov; 53(2):255-262. PubMed ID: 29740728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malpositioning of a pacemaker lead to the left ventricle accompanied by posterior mitral leaflet injury.
    Seki H; Fukui T; Shimokawa T; Manabe S; Watanabe Y; Chino K; Takanashi S
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):235-7. PubMed ID: 19038982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
    Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
    J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the transvenous extraction of cardioverter-defibrillator leads more hazardous than that of pacemaker leads?
    Małecka B; Kutarski A; Grabowski M
    Kardiol Pol; 2010 Aug; 68(8):884-90. PubMed ID: 20730717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The significance of electrocardiogram in the estimation of correct lead position in patients with permanent ventricular pacing].
    Zielińska M; Kaczmarek K; Koniarek W; Goch JH
    Wiad Lek; 2006; 59(7-8):580-4. PubMed ID: 17209366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of iatrogenic cardiac perforation caused by pacemaker and defibrillator leads.
    Rajkumar CA; Claridge S; Jackson T; Behar J; Johnson J; Sohal M; Amraoui S; Nair A; Preston R; Gill J; Rajani R; Rinaldi CA
    Europace; 2017 Jun; 19(6):1031-1037. PubMed ID: 27353321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late complications of electrotherapy - a clinical analysis of indications for transvenous removal of endocardial leads: a single centre experience.
    Polewczyk A; Kutarski A; Tomaszewski A; Polewczyk M; Janion M
    Kardiol Pol; 2013; 71(4):366-72. PubMed ID: 23788342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.